Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists

Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists

US Patent 10047048 · Granted Aug 14, 2018

Estimated economic value: $8,712,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oral formulations of pyrrolidine derivatives2022
Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists2022
Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]2020
Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists2020
Oral formulations of pyrrolidine derivatives2019
Oral formulations of pyrrolidine derivatives2018
Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]2017
Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists2017